BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26300548)

  • 1. The functional relevance of somatic synonymous mutations in melanoma and other cancers.
    Gotea V; Gartner JJ; Qutob N; Elnitski L; Samuels Y
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):673-84. PubMed ID: 26300548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.
    Gartner JJ; Parker SC; Prickett TD; Dutton-Regester K; Stitzel ML; Lin JC; Davis S; Simhadri VL; Jha S; Katagiri N; Gotea V; Teer JK; Wei X; Morken MA; Bhanot UK; ; Chen G; Elnitski LL; Davies MA; Gershenwald JE; Carter H; Karchin R; Robinson W; Robinson S; Rosenberg SA; Collins FS; Parmigiani G; Komar AA; Kimchi-Sarfaty C; Hayward NK; Margulies EH; Samuels Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13481-6. PubMed ID: 23901115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposing synonymous mutations.
    Hunt RC; Simhadri VL; Iandoli M; Sauna ZE; Kimchi-Sarfaty C
    Trends Genet; 2014 Jul; 30(7):308-21. PubMed ID: 24954581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
    Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
    Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies.
    Colebatch AJ; Di Stefano L; Wong SQ; Hannan RD; Waring PM; Dobrovic A; McArthur GA; Papenfuss AT
    Oncotarget; 2016 Oct; 7(41):66569-66585. PubMed ID: 27611953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviewing the somatic genetics of melanoma: from current to future analytical approaches.
    Dutton-Regester K; Hayward NK
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):144-54. PubMed ID: 22248438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pan-cancer analysis of synonymous mutations.
    Sharma Y; Miladi M; Dukare S; Boulay K; Caudron-Herger M; Groß M; Backofen R; Diederichs S
    Nat Commun; 2019 Jun; 10(1):2569. PubMed ID: 31189880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of melanoma: recent advances.
    Hill VK; Gartner JJ; Samuels Y; Goldstein AM
    Annu Rev Genomics Hum Genet; 2013; 14():257-79. PubMed ID: 23875803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASopathy Gene Mutations in Melanoma.
    Halaban R; Krauthammer M
    J Invest Dermatol; 2016 Sep; 136(9):1755-1759. PubMed ID: 27236105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin cancer risk in BRCA1/2 mutation carriers.
    Gumaste PV; Penn LA; Cymerman RM; Kirchhoff T; Polsky D; McLellan B
    Br J Dermatol; 2015 Jun; 172(6):1498-1506. PubMed ID: 25524463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for background mutation frequency biases improves the identification of cancer driver genes.
    Evans P; Avey S; Kong Y; Krauthammer M
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delving into somatic variation in sporadic melanoma.
    Walia V; Mu EW; Lin JC; Samuels Y
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):155-70. PubMed ID: 22260482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of NTRK1 mutations identified in melanoma.
    Miranda C; Mazzoni M; Sensi M; Pierotti MA; Greco A
    Genes Chromosomes Cancer; 2014 Oct; 53(10):875-80. PubMed ID: 24965840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the BRAF
    Richtig G; Hoeller C; Kashofer K; Aigelsreiter A; Heinemann A; Kwong LN; Pichler M; Richtig E
    Br J Dermatol; 2017 Oct; 177(4):936-944. PubMed ID: 28278349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple roles of NF1 in the melanocyte lineage.
    Larribère L; Utikal J
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic driver mutations in melanoma.
    Reddy BY; Miller DM; Tsao H
    Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatic Mutations Associated with Metastasis in Acral Melanoma].
    Abramov IS; Emelyanova MA; Ryabaya OO; Krasnov GS; Zasedatelev AS; Nasedkina TV
    Mol Biol (Mosk); 2019; 53(4):648-653. PubMed ID: 31397438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.